-
Role of haloperidol in palliative medicine: an update.
The American journal of hospice & palliative care 20120601
-
Butyrophenone on O-TiO2(110): one-dimensional motion in a weakly confined potential well.
ACS nano 20120424
-
Evidence of Haldol (haloperidol) long-term intoxication.
Forensic science international 20120210
-
Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.
Bioorganic & medicinal chemistry 20120201
-
The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup.
The western journal of emergency medicine 20120201
-
Update on the role of antipsychotics in the treatment of Tourette syndrome.
Neuropsychiatric disease and treatment 20120101
-
Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychotics.
PloS one 20120101
-
Auditing clinical outcomes after introducing off-licence prescribing of atypical antipsychotic melperone for patients with treatment refractory schizophrenia.
TheScientificWorldJournal 20120101
-
Photochemistry of 2-diphenylmethoxyacetophenone. Direct detection of a long-lived enol from a Norrish Type II photoreaction.
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20110901
-
[Loss of visual acuity after treatment with pipamperone].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20110801
-
Haloperidol disrupts opioid-antinociceptive tolerance and physical dependence.
The Journal of pharmacology and experimental therapeutics 20110701
-
Are butyrophenones effective for the treatment of primary headache in the emergency department?
CJEM 20110301
-
An extraction technique for analytical sample preparation in aqueous solution based on controlling dispersion of ionic surfactant assemblies in isotachophoretic migration.
Journal of chromatography. A 20110107
-
New thoughts on thought disorders in Parkinson's disease: review of current research strategies and challenges.
Parkinson's disease 20110101
-
Neuroprotective effects of alpha lipoic Acid on haloperidol-induced oxidative stress in the rat brain.
Cell & bioscience 20110101
-
Parkinson's disease and anaesthesia.
Indian journal of anaesthesia 20110101
-
Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians.
BMC neurology 20110101
-
Olfactory cues from plants infected by powdery mildew guide foraging by a mycophagous ladybird beetle.
PloS one 20110101
-
Differential changes in QTc duration during in-hospital haloperidol use.
PloS one 20110101
-
Treating nausea and vomiting in palliative care: a review.
Clinical interventions in aging 20110101
-
Diagnostic dilemma in a child with tuberculous meningitis on haloperidol therapy.
Toxicology international 20110101
-
Current concepts in the management of postoperative nausea and vomiting.
Anesthesiology research and practice 20110101
-
Are prescribing doctors sensitive to the price that their patients have to pay in the Spanish National Health System?
BMC health services research 20110101
-
Droperidol for treatment of nausea and vomiting in palliative care patients.
The Cochrane database of systematic reviews 20101006
-
The subtype-specific effects of droperidol on action potential duration in cellular and computational models of long QT syndrome.
Anesthesia and analgesia 20100901
-
Antagonist-D2S-dopamine receptor interactions in intact recombinant Chinese hamster ovary cells [corrected].
Fundamental & clinical pharmacology 20100601
-
Effect of alkyl substituents on photorelease from butyrophenone derivatives.
The Journal of organic chemistry 20100305
-
MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion.
Synapse (New York, N.Y.) 20100101
-
Acute gastroenteritis: from guidelines to real life.
Clinical and experimental gastroenterology 20100101
-
4-(4-Chloro-phen-yl)-1-[3-(4-fluoro-benzo-yl)prop-yl]-4-hydroxy-piperidin-1-ium 2,4,6-trinitro-phenolate (haloperidol picrate).
Acta crystallographica. Section E, Structure reports online 20091001
-
[Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
L'Encephale 20090901
-
Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
Human psychopharmacology 20090701
-
Automated on-line in-tube solid-phase microextraction coupled with HPLC/MS/MS for the determination of butyrophenone derivatives in human plasma.
Analytical and bioanalytical chemistry 20090601
-
The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice.
Brain research bulletin 20090429
-
Spiperone enhances intracellular calcium level and inhibits the Wnt signaling pathway.
BMC pharmacology 20090101
-
Determination of gaseous organic compounds in Hyogo Prefecture, Japan.
The Southeast Asian journal of tropical medicine and public health 20081101
-
Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one.
Bioorganic & medicinal chemistry 20080801
-
Antagonist-radioligand binding to D2L-receptors in intact cells.
Biochemical pharmacology 20080601
-
Chemotherapy-and cancer-related nausea and vomiting.
Current oncology (Toronto, Ont.) 20080101
-
Rational design, synthesis and evaluation of (6aR( *),11bS( *))-1-(4-fluorophenyl)-4-{7-[4-(4-fluorophenyl)-4-oxobutyl]1,2,3,4,6,6a,7,11b,12,12a(RS)-decahydropyrazino[2',1':6,1]pyrido[3,4-b]indol-2-yl}-butan-1-one as a potential neuroleptic agent.
Bioorganic & medicinal chemistry 20071201
-
A prototypical Sigma-1 receptor antagonist protects against brain ischemia.
Brain research 20071121
-
Synthesis and binding affinity of new pyrazole and isoxazole derivatives as potential atypical antipsychotics.
Bioorganic & medicinal chemistry letters 20070901
-
Pesticides in surface drinking-water supplies of the northern Great Plains.
Environmental health perspectives 20070801
-
Fifty years chlorpromazine: a historical perspective.
Neuropsychiatric disease and treatment 20070801
-
Haloperidol induces neurotoxicity by the NMDA receptor downstream signaling pathway, alternative from glutamate excitotoxicity.
Neurochemistry international 20070601
-
Effects of haloperidol and its pyridinium metabolite on plasma membrane permeability and fluidity in the rat brain.
Progress in neuro-psychopharmacology & biological psychiatry 20070509
-
Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting.
Canadian journal of anaesthesia = Journal canadien d'anesthesie 20070501
-
Methyl chloroacetate as an extraction solvent for coupling liquid-liquid semimicroextraction with micellar electrokinetic chromatography through on-capillary decomposition for the separation of neutral compounds with concentration enhancement.
Journal of chromatography. A 20070413
-
Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070401
-
Inhibition of carbonyl reductase activity in pig heart by alkyl phenyl ketones.
Journal of enzyme inhibition and medicinal chemistry 20070201
-
Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005.
BMC clinical pharmacology 20070101
-
Forty years of antipsychotic Drug research--from haloperidol to paliperidone--with Dr. Paul Janssen.
Arzneimittel-Forschung 20070101
-
Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients.
The Annals of pharmacotherapy 20061101
-
QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine.
Neuropharmacology 20060801
-
Successful treatment of six patients with neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure.
Renal failure 20060101
-
Synthesis, neutron structure, and reactivity of the bis(dihydrogen) complex RuH2(eta(2)-H2)2(PCyp3)2 stabilized by two tricyclopentylphosphines.
Journal of the American Chemical Society 20051221
-
Haloperidol: an alternative butyrophenone for nausea and vomiting prophylaxis in anesthesia.
AANA journal 20050801
-
Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives.
Bioorganic & medicinal chemistry letters 20050701
-
Benperidol for schizophrenia.
The Cochrane database of systematic reviews 20050418
-
Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.
The Journal of clinical psychiatry 20050301
-
Factors related to prescription dosage in Japanese psychiatric hospitals.
Psychiatry and clinical neurosciences 20050201
-
The haloperidol story.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101
-
Haloperidol: towards further understanding of the structural contributions of its pharmacophoric elements at D2-like receptors.
Bioorganic & medicinal chemistry letters 20041206
-
[Butyrophenone derivatives].
Nihon rinsho. Japanese journal of clinical medicine 20041201
-
Multiresidue method for the detection of tranquillisers, xylazine, and a beta-blocker in animal production by liquid chromatography-tandem mass spectrometry.
Journal of chromatography. A 20041029
-
Droperidol for acute psychosis.
The Cochrane database of systematic reviews 20041018
-
A review of drugs and techniques used for sedation and anaesthesia in captive rhinoceros species.
Australian veterinary journal 20040901
-
Antipsychotics and the risk of sudden cardiac death.
Archives of internal medicine 20040628
-
Rhodium-catalyzed addition/ring-opening reaction of arylboronic acids with cyclobutanones.
Organic letters 20040415
-
[Injection anesthesia administered in the mid-anesthesia period after ether induction in laboratory rats].
Ceskoslovenska fysiologie 20031201
-
The evolving management of migraine.
Current opinion in neurology 20030601
-
Droperidol, QT prolongation, and sudden death: what is the evidence?
Annals of emergency medicine 20030401
-
The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.
Schizophrenia research 20030101
-
Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine.
Pharmacopsychiatry 20030101
-
Functional cooperation between neurosteroids and D2 dopamine antagonists on KCl-evoked [3H]noradrenaline release: modulation by calcium channel blockers.
Journal of neuroendocrinology 20021201
-
Metabolism and excretion of centbutindole (neuroleptic) in rats after oral administration.
The Journal of pharmacy and pharmacology 20021201
-
Platelet serotonin transporter in schizophrenic patients with and without neuroleptic treatment.
Neurochemistry international 20021001
-
Antipsychotics: impact on prolactin levels.
Expert opinion on pharmacotherapy 20021001
-
A hybrid microdevice for electrophoresis and electrochromatography using UV detection.
Electrophoresis 20021001
-
Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism.
Thrombosis and haemostasis 20020801
-
Differential inhibition of T-type calcium channels by neuroleptics.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20020115
-
Benperidol for schizophrenia.
The Cochrane database of systematic reviews 20020101
-
Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia.
Human psychopharmacology 20020101
-
Comparative efficacy of centbutindole & risperidone in schizophrenia.
Indian journal of psychiatry 20020101
-
Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings.
Behavioural pharmacology 20010901
-
Effect of hyperprolactinemia induced by pituitary grafts or castration on porphyrin content of the mouse Harderian gland.
The Journal of toxicological sciences 20010801
-
Use of olanzapine in non-psychotic psychiatric disorders.
Expert opinion on pharmacotherapy 20010401
-
Suspected induction of a pyoderma gangrenosum-like eruption due to sulpiride treatment.
Cutis 20010301
-
Droperidol for acute psychosis.
The Cochrane database of systematic reviews 20010101
